OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comparison of Disk Diffusion, E-Test, and Broth Microdilution Methods for Testing In Vitro Activity of Cefiderocol in Acinetobacter baumannii
Natalia Kolesnik-Goldmann, Helena M. B. Seth-Smith, Klara Haldimann, et al.
Antibiotics (2023) Vol. 12, Iss. 7, pp. 1212-1212
Open Access | Times Cited: 12
Natalia Kolesnik-Goldmann, Helena M. B. Seth-Smith, Klara Haldimann, et al.
Antibiotics (2023) Vol. 12, Iss. 7, pp. 1212-1212
Open Access | Times Cited: 12
Showing 12 citing articles:
Cefiderocol susceptibility testing: the challenge of disc diffusion
Katy Jeannot, Laurent Dortet
Clinical Microbiology and Infection (2025)
Closed Access | Times Cited: 1
Katy Jeannot, Laurent Dortet
Clinical Microbiology and Infection (2025)
Closed Access | Times Cited: 1
Impact of media brand on cefiderocol disk diffusion results
Mia DeMarco, Allison M. Field, L. E. Donohue, et al.
Journal of Clinical Microbiology (2025)
Open Access
Mia DeMarco, Allison M. Field, L. E. Donohue, et al.
Journal of Clinical Microbiology (2025)
Open Access
Molecular epidemiology of invasive Group A streptococcal infections before and after the COVID-19 pandemic in Switzerland
Angeliki M. Andrianaki, Federica Andreoni, Jessica Franz, et al.
CMI Communications (2024) Vol. 1, Iss. 1, pp. 100004-100004
Open Access | Times Cited: 3
Angeliki M. Andrianaki, Federica Andreoni, Jessica Franz, et al.
CMI Communications (2024) Vol. 1, Iss. 1, pp. 100004-100004
Open Access | Times Cited: 3
Comparison of available methods to evaluate cefiderocol susceptibility in Acinetobacter spp
Fernando Pasterán, O. Andrea Wong, Vyanka Mezcord, et al.
Journal of Microbiological Methods (2024) Vol. 223, pp. 106972-106972
Open Access | Times Cited: 3
Fernando Pasterán, O. Andrea Wong, Vyanka Mezcord, et al.
Journal of Microbiological Methods (2024) Vol. 223, pp. 106972-106972
Open Access | Times Cited: 3
Synthesis, Characterization, and Performance of Zirconia Nanoparticulates as an Antibacterial, Antifungal, and Anticancer Activity Agent
Shrey K. Modi, Monika Nehra, Sandeep Kumar, et al.
BioNanoScience (2024) Vol. 14, Iss. 3, pp. 2529-2540
Closed Access | Times Cited: 3
Shrey K. Modi, Monika Nehra, Sandeep Kumar, et al.
BioNanoScience (2024) Vol. 14, Iss. 3, pp. 2529-2540
Closed Access | Times Cited: 3
Issues with Cefiderocol Testing: Comparing Commercial Methods to Broth Microdilution in Iron-Depleted Medium—Analyses of the Performances, ATU, and Trailing Effect According to EUCAST Initial and Revised Interpretation Criteria
Stefano Stracquadanio, Alice Nicolosi, Andrea Marıno, et al.
Diagnostics (2024) Vol. 14, Iss. 20, pp. 2318-2318
Open Access | Times Cited: 3
Stefano Stracquadanio, Alice Nicolosi, Andrea Marıno, et al.
Diagnostics (2024) Vol. 14, Iss. 20, pp. 2318-2318
Open Access | Times Cited: 3
A multicenter performance evaluation of cefiderocol MIC results: ComASP in comparison to CLSI broth microdilution
Laura Koeth, Jeanna DiFranco-Fisher, Elizabeth Palavecino, et al.
Journal of Clinical Microbiology (2024)
Closed Access | Times Cited: 3
Laura Koeth, Jeanna DiFranco-Fisher, Elizabeth Palavecino, et al.
Journal of Clinical Microbiology (2024)
Closed Access | Times Cited: 3
Commercially available tests for determining cefiderocol susceptibility display variable performance in the Achromobacter genus
Vincent Jean-Pierre, Pauline Sorlin, Katy Jeannot, et al.
Annals of Clinical Microbiology and Antimicrobials (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Vincent Jean-Pierre, Pauline Sorlin, Katy Jeannot, et al.
Annals of Clinical Microbiology and Antimicrobials (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Challenges Facing Two Outbreaks of Carbapenem-Resistant Acinetobacter baumannii: From Cefiderocol Susceptibility Testing to the Emergence of Cefiderocol-Resistant Mutants
Montserrat Rodríguez-Aguirregabiria, Fernando Lázaro-Perona, Juana Cacho-Calvo, et al.
Antibiotics (2024) Vol. 13, Iss. 8, pp. 784-784
Open Access | Times Cited: 2
Montserrat Rodríguez-Aguirregabiria, Fernando Lázaro-Perona, Juana Cacho-Calvo, et al.
Antibiotics (2024) Vol. 13, Iss. 8, pp. 784-784
Open Access | Times Cited: 2
Real-world performance of susceptibility testing for cefiderocol: insights from a prospective multicentre study on Gram-negative bacteria
Álvaro Irigoyen, Azahara Ocaña, Rosa Sánchez-Mayoral, et al.
JAC-Antimicrobial Resistance (2024) Vol. 6, Iss. 5
Open Access | Times Cited: 2
Álvaro Irigoyen, Azahara Ocaña, Rosa Sánchez-Mayoral, et al.
JAC-Antimicrobial Resistance (2024) Vol. 6, Iss. 5
Open Access | Times Cited: 2
Molecular epidemiology of invasive Group A Streptococcal infections before and after the COVID-19 pandemic in Switzerland
Angeliki M. Andrianaki, Jessica Franz, Federica Andreoni, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Angeliki M. Andrianaki, Jessica Franz, Federica Andreoni, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Comparison of Available Methods to Evaluate Cefiderocol Susceptibility in Acinetobacter Spp
Fernando Pasterán, O. Andrea Wong, Vyanka Mezcord, et al.
(2024)
Closed Access
Fernando Pasterán, O. Andrea Wong, Vyanka Mezcord, et al.
(2024)
Closed Access
Transmission cluster of cefiderocol-non-susceptible carbapenem-resistant Acinetobacter baumannii in cefiderocol-naïve individuals
Claudia Alteri, Antonio Teri, Maria Francesca Liporace, et al.
Annals of Clinical Microbiology and Antimicrobials (2024) Vol. 23, Iss. 1
Open Access
Claudia Alteri, Antonio Teri, Maria Francesca Liporace, et al.
Annals of Clinical Microbiology and Antimicrobials (2024) Vol. 23, Iss. 1
Open Access
